CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Med, Dev Officer Dana Pizzuti sold $645K of Crinetics Pharmaceuticals, Inc.
Sold$645,006
$44.87Price
14,375Shares
−34%Stake
What CRNX did after the filing
- The stock from Fri, Jul 5 close, $43.83
- +17.8%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Aug 16 close.
Traded Wed, Jul 3. Filed Fri, Jul 5, 12:30 PM ET, during the session. Returns use the Jul 5 close and the Aug 16 close. Not investment advice.